LGT Group Foundation Purchases 15,799 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

LGT Group Foundation boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 18.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 101,731 shares of the medical instruments supplier’s stock after purchasing an additional 15,799 shares during the quarter. LGT Group Foundation’s holdings in DENTSPLY SIRONA were worth $1,520,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. QVIDTVM Management LLC boosted its stake in DENTSPLY SIRONA by 1.1% in the 1st quarter. QVIDTVM Management LLC now owns 463,866 shares of the medical instruments supplier’s stock valued at $6,930,000 after purchasing an additional 5,000 shares during the period. Nuveen LLC bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at $6,299,000. Aigen Investment Management LP bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at $177,000. Entropy Technologies LP boosted its stake in DENTSPLY SIRONA by 116.7% in the 1st quarter. Entropy Technologies LP now owns 72,002 shares of the medical instruments supplier’s stock valued at $1,076,000 after purchasing an additional 38,783 shares during the period. Finally, Invesco Ltd. boosted its stake in DENTSPLY SIRONA by 31.2% in the 1st quarter. Invesco Ltd. now owns 523,317 shares of the medical instruments supplier’s stock valued at $7,818,000 after purchasing an additional 124,327 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $13.05 on Wednesday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $27.48. The stock has a market capitalization of $2.60 billion, a P/E ratio of -2.75, a price-to-earnings-growth ratio of 0.78 and a beta of 0.94. The stock has a fifty day moving average of $15.59 and a 200-day moving average of $15.81.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The company had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. During the same quarter in the previous year, the firm earned $0.49 EPS. DENTSPLY SIRONA’s revenue was down 4.9% on a year-over-year basis. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Analysts Set New Price Targets

Several analysts recently issued reports on XRAY shares. Piper Sandler reduced their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. UBS Group cut their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Barrington Research set a $18.00 target price on DENTSPLY SIRONA and gave the company an “outperform” rating in a research report on Friday. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Finally, Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.